Search Results

3976 - 4000 of 103743
TitleWireDateTime
WTW 2026 Best Practices in Healthcare Survey: U.S. employer healthcare costs set to rise at fastest pace in more than two decades Globe Newswire 10/28 10:03
Clinical Trial Supply and Logistics Market Forecast to Reach USD 8.58 Billion by 2034 as Biologics, Global Trials and Cold-Chain Requirements Reshape Supply Networks Globe Newswire 10/28 10:00
EmpowerFresh and Loyalty Lane Announce Partnership to Bring AI-Driven Ordering and Inventory Management to Independent Grocers Globe Newswire 10/28 10:00
Delta Media Group introduces Intelligent Websites, powered by new Delta Connected Intelligence technology Globe Newswire 10/28 10:00
Joint Commission Enterprise Appoints Dr. Subashnie Devkaran to Lead International Strategy and Operations Globe Newswire 10/28 10:00
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against D-Wave Quantum Inc. (NASDAQ: QBTS) — Investors Who Suffered Losses Are Encouraged to Contact the Firm Globe Newswire 10/28 10:00
Buy Now Pay Later Market to Reach USD 90.25 Billion by 2035 as New Rules, Card-Based Installments and Fresh Funding Deals Reshape Competition Globe Newswire 10/28 10:00
Opterrix Launches AI-Powered Portfolio Management Workflow to Transform How Insurers Analyze and Manage Risk Globe Newswire 10/28 10:00
Bronstein, Gewirtz & Grossman LLC Urges York Space Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm Globe Newswire 10/28 10:00
Freight Right MCP Now Available in Grok Bot and Cursor Globe Newswire 10/28 10:00
Sands Investment Group Appoints Clifford Moskowitz as National Executive Managing Director Globe Newswire 10/28 10:00
Fraud News Network Surpasses 100,000 Milestone Downloads Across iOS and Android as Investor Demand for Real-Time Fraud Intelligence Surges Globe Newswire 10/28 09:57
BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
PAPA JOHN’S INTERNATIONAL, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 2, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
HONEYWELL AEROSPACE INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 23, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
LINCOLN EDUCATIONAL SERVICES CORPORATION INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
DOXIMITY, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 16, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
YORK SPACE SYSTEMS INC. INVESTORS WITH LOSSES HAVE UNTIL OCTOBER 30, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
BAIDU, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 13, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
AST SPACEMOBILE, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 13, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
APPLOVIN CORPORATION INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 16, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
DICK’S SPORTING GOODS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
FUELCELL ENERGY, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Globe Newswire 10/28 09:48
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ultralife Corporation (Nasdaq – ULBI), QIAGEN N.V. (NYSE – QGEN), CCC Intelligent Solutions Holdings Inc. (Nasdaq – CCC), Penske Automotive Group, Inc. (NYSE – PAG) Globe Newswire 10/28 09:40
Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer Globe Newswire 10/28 09:40
3976 - 4000 of 103743

News, Photo and Web Search

Search News by Ticker